Veralipride

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Veralipride
Veralipride.svg
Ball-and-stick model of the veralipride molecule
Systematic (IUPAC) name
2,3-dimethoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide
Clinical data
Trade names Agreal, Agradil
Legal status
  • ℞ (Prescription only)
Routes of
administration		 Oral
Identifiers
CAS Number 66644-81-3 YesY
ATC code N05AL06 (WHO)
PubChem CID: 47979
ChemSpider 43638 N
UNII S7064109UD YesY
Chemical data
Formula C17H25N3O5S
Molecular mass 383.4625 g/mol
  • COC1=CC(=CC(=C1OC)C(=O)NCC2CCCN2CC=C)S(=O)(=O)N
  • InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23) N
  • Key:RYJXBGGBZJGVQF-UHFFFAOYSA-N N
 NYesY (what is this?)  (verify)

Veralipride (Agreal, Agradil) is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. Veralipride has never gained approval in the United States.

In September 2006, it was withdrawn from the Spanish market. As a result, the European Commission referred the matter to the European Medicines Agency (EMA). On July 2007, the EMA recommended the withdrawal of marketing authorisations for veralipride.[1]

See also

References

  1. ↑ OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF MEDICINAL PRODUCTS CONTAINING VERALIPRIDE (from the EMEA website)

<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=Veralipride&oldid=3298638"